ReviewMedicine2026
Rectal metastasis from primary small-cell lung cancer: A case report and literature review.
Review in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleSmall-cell lung cancer (SCLC) is a subtype of primary lung cancer that has a very poor overall survival rate because of its propensity for metastasis and incredibly high proliferation rate. For most patients with lung cancer, metastatic disease is discovered at the time of initial diagnosis. About 70% of individuals with SCLC already have metastases in their brain, liver, lymph nodes, and bones at the time of diagnosis. Rectal metastases are uncommon. PATIENT CONCERNS: In this case report, we described a 73-year-old female patient who was diagnosed with neuroendocrine SCLC based on a lung biopsy obtained by needle. The patient had blood in the stool, accompanied by loss of appetite and pain around the umbilicus for 6 months. The symptoms gradually worsened. DIAGNOSES: Rectal pathological results revealed that metastatic poorly differentiated neuroendocrine carcinoma originated from the lung.
interventionsThe patient underwent 4 courses of chemotherapy. OUTCOMES: The hematochezia then subsided, and radiological evaluation of the rectal metastases and primary lung tumors suggested a partial response. LESSONS: When a rectal tumor is identified, it is important to differentiate metastatic diseases and make a definitive diagnosis through detailed immunohistochemical evaluation and systemic imaging surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.